Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Exploring the cardiac response to injury in heart transplant biopsies
Philip F. Halloran, … , Andreas Zuckermann, Michael D. Parkes
Philip F. Halloran, … , Andreas Zuckermann, Michael D. Parkes
Published October 18, 2018
Citation Information: JCI Insight. 2018;3(20):e123674. https://doi.org/10.1172/jci.insight.123674.
View: Text | PDF
Clinical Medicine Cardiology Transplantation

Exploring the cardiac response to injury in heart transplant biopsies

  • Text
  • PDF
Abstract

BACKGROUND. Because injury is universal in organ transplantation, heart transplant endomyocardial biopsies present an opportunity to explore response to injury in heart parenchyma. Histology has limited ability to assess injury, potentially confusing it with rejection, whereas molecular changes have potential to distinguish injury from rejection. Building on previous studies of transcripts associated with T cell–mediated rejection (TCMR) and antibody-mediated rejection (ABMR), we explored transcripts reflecting injury. METHODS. Microarray data from 889 prospectively collected endomyocardial biopsies from 454 transplant recipients at 14 centers were subjected to unsupervised principal component analysis and archetypal analysis to detect variation not explained by rejection. The resulting principal component and archetype scores were then examined for their transcript, transcript set, and pathway associations and compared to the histology diagnoses and left ventricular function. RESULTS. Rejection was reflected by principal components PC1 and PC2, and by archetype scores S2TCMR, and S3ABMR, with S1normal indicating normalness. PC3 and a new archetype score, S4injury, identified unexplained variation correlating with expression of transcripts inducible in injury models, many expressed in macrophages and associated with inflammation in pathway analysis. S4injury scores were high in recent transplants, reflecting donation-implantation injury, and both S4injury and S2TCMR were associated with reduced left ventricular ejection fraction. CONCLUSION. Assessment of injury is necessary for accurate estimates of rejection and for understanding heart transplant phenotypes. Biopsies with molecular injury but no molecular rejection were often misdiagnosed rejection by histology. TRAIL REGISTRATION. ClinicalTrials.gov NCT02670408 FUNDING. Roche Organ Transplant Research Foundation, the University of Alberta Hospital Foundation, and Alberta Health Services.

Authors

Philip F. Halloran, Jeff Reeve, Arezu Z. Aliabadi, Martin Cadeiras, Marisa G. Crespo-Leiro, Mario Deng, Eugene C. Depasquale, Johannes Goekler, Xavier Jouven, Daniel H. Kim, Jon Kobashigawa, Alexandre Loupy, Peter Macdonald, Luciano Potena, Andreas Zuckermann, Michael D. Parkes

×

Figure 4

Running average of LVEF versus archetype scores.

Options: View larger image (or click on image) Download as PowerPoint
Running average of LVEF versus archetype scores.
For each of the 4 arche...
For each of the 4 archetype scores, the 606 biopsies with available LVEF data were sorted by the archetype score being plotted. A sliding window of size n = 85 biopsies was then used to plot the mean LVEF versus mean archetype score. For example, the first data point on the left on the S1normal line corresponds to the mean LVEF and mean S1normal of the first through 85th biopsies (sorted in ascending order of the 606 S1normal scores), the second point to the second through 86th biopsies, etc. The lines have different x-axis ranges because, for example, the highest 85 S2TCMR scores are approximately 0.4, while the highest 85 scores for each of S1normal, S3ABMR, and S4injury are larger.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts